Par Pharmaceutical Companies, Inc. (NYSE-Listed PRX) visits the NYSE to celebrate the company's 25th anniversary of listing on the NYSE. In honor of the occasion, Chairman and CEO Pat LePore rings The Closing BellSM.|
Watch the video of the ringing.
About Par Pharmaceutical Companies, Inc. (NYSE: PRX):
Par Pharmaceutical Companies, Inc. is a U.S.-based specialty pharmaceutical company. Through its wholly-owned subsidiary's two operating divisions, Par Pharmaceutical and Strativa Pharmaceuticals, it develops, manufactures and markets higher-barrier-to-entry generic drugs and niche, innovative proprietary pharmaceuticals. For press releases and other company information, visit www.parpharm.com. (Sourced by Par Pharmaceutical Companies, Inc.)